Convenio Suministro Medicamentos Diabetes y Cintas
El requerimiento de los servicios clínicos del Hospital. Que mediante acuerdo del Comité de Farmacia se resolvió la necesidad de licitar estos medicamentos. Que este proceso debe realizarce mediante licitación pública y que por ende es necesario dictar
13 oferente(s) participaron en esta licitación. El detalle de quién compitió y con qué oferta está en el registro oficial de Mercado Público.
Ver oferentes en Mercado Público →| Código | Fecha | Proveedor | Monto |
|---|---|---|---|
| 4661-1129-SE15 | 07-07-2015 | Novo Nordisk Farmaceutica Limitada | $2.231.488 |
| 4661-953-SE15 | 04-06-2015 | Aventis Pharma Holding Gmbh | $333.200 |
| 4661-871-SE15 | 19-05-2015 | Novo Nordisk Farmaceutica Limitada | $981.036 |
| 4661-757-SE15 | 23-04-2015 | Aventis Pharma Holding Gmbh | $19.565.004 |
| 4661-715-SE15 | 15-04-2015 | Aventis Pharma Holding Gmbh | $4.228.308 |
| 4661-599-SE15 | 02-04-2015 | Aventis Pharma Holding Gmbh | $2.447.354 |
| 4661-538-SE15 | 25-03-2015 | Aventis Pharma Holding Gmbh | $2.771.962 |
| 4661-474-SE15 | 16-03-2015 | Aventis Pharma Holding Gmbh | $2.921.331 |
| 4661-414-SE15 | 09-03-2015 | Aventis Pharma Holding Gmbh | $3.421.131 |
| 4661-361-SE15 | 02-03-2015 | Aventis Pharma Holding Gmbh | $3.745.739 |
| 4661-292-SE15 | 16-02-2015 | Aventis Pharma Holding Gmbh | $333.200 |
| 4661-296-SE15 | 16-02-2015 | Novofarma Service S.A. | $3.844.771 |
| 4661-173-SE15 | 30-01-2015 | Novo Nordisk Farmaceutica Limitada | $2.722.006 |
| 4661-178-SE15 | 30-01-2015 | Aventis Pharma Holding Gmbh | $4.394.956 |
| 4661-162-SE15 | 29-01-2015 | Novo Nordisk Farmaceutica Limitada | $784.829 |
| 4661-121-SE15 | 23-01-2015 | Aventis Pharma Holding Gmbh | $4.248.847 |
| 4661-28-SE15 | 12-01-2015 | Aventis Pharma Holding Gmbh | $5.535.285 |
| 4586-82-SE15 | 08-01-2015 | Productos Farmoquimicos Roche Limitada | $7.140.000 |
| 4661-1706-SE14 | 18-12-2014 | Aventis Pharma Holding Gmbh | $5.389.272 |
| 4661-1704-SE14 | 18-12-2014 | Instituto Sanitas S.A. | $303.450 |
| 4661-1709-SE14 | 18-12-2014 | Novo Nordisk Farmaceutica Limitada | $1.162.725 |
| 4586-4501-SE14 | 10-12-2014 | Productos Farmoquimicos Roche Limitada | $7.140.000 |
| 4661-1656-SE14 | 09-12-2014 | Novofarma Service S.A. | $3.844.771 |
| 4661-1645-SE14 | 09-12-2014 | Aventis Pharma Holding Gmbh | $4.636.264 |
| 4661-1650-SE14 | 09-12-2014 | Instituto Sanitas S.A. | $303.450 |
| 4661-1537-SE14 | 25-11-2014 | Aventis Pharma Holding Gmbh | $2.280.754 |
| 4661-1540-SE14 | 25-11-2014 | Novo Nordisk Farmaceutica Limitada | $476.000 |
| 4586-4258-SE14 | 17-11-2014 | Productos Farmoquimicos Roche Limitada | $5.712.000 |
| 4661-1443-SE14 | 04-11-2014 | Aventis Pharma Holding Gmbh | $2.771.962 |
| 4661-1414-SE14 | 28-10-2014 | Novo Nordisk Farmaceutica Limitada | $2.131.314 |
| 4661-1397-SE14 | 27-10-2014 | Aventis Pharma Holding Gmbh | $3.599.631 |
| 4661-1372-SE14 | 20-10-2014 | Aventis Pharma Holding Gmbh | $4.248.895 |
| 4661-1340-SE14 | 06-10-2014 | Aventis Pharma Holding Gmbh | $2.114.154 |
| 4586-3785-SE14 | 01-10-2014 | Productos Farmoquimicos Roche Limitada | $5.712.000 |
| 4661-1301-SE14 | 29-09-2014 | Novo Nordisk Farmaceutica Limitada | $1.719.217 |
| 4661-1288-SE14 | 24-09-2014 | Aventis Pharma Holding Gmbh | $3.421.131 |
| 4661-1249-SE14 | 12-09-2014 | Aventis Pharma Holding Gmbh | $1.473.577 |
| 4586-3546-SE14 | 09-09-2014 | Productos Farmoquimicos Roche Limitada | $4.998.000 |
| 4661-1236-SE14 | 09-09-2014 | Novofarma Service S.A. | $2.691.340 |
| 4661-1216-SE14 | 08-09-2014 | Aventis Pharma Holding Gmbh | $1.947.554 |
| 4661-1180-SE14 | 02-09-2014 | Aventis Pharma Holding Gmbh | $1.947.554 |
| 4661-1169-SE14 | 01-09-2014 | Novo Nordisk Farmaceutica Limitada | $1.174.816 |
| 4661-942-SE14 | 27-08-2014 | Instituto Sanitas S.A. | $202.300 |
| 4661-1144-SE14 | 25-08-2014 | Aventis Pharma Holding Gmbh | $4.248.895 |
| 4661-915-SE14 | 25-08-2014 | Novofarma Service S.A. | $2.306.863 |
| 4661-1091-SE14 | 11-08-2014 | Aventis Pharma Holding Gmbh | $1.306.977 |
| 4661-1069-SE14 | 06-08-2014 | Instituto Sanitas S.A. | $202.300 |
| 4661-1063-SE14 | 05-08-2014 | Novofarma Service S.A. | $2.691.340 |
| 4661-994-SE14 | 28-07-2014 | Aventis Pharma Holding Gmbh | $3.570.595 |
| 4661-999-SE14 | 28-07-2014 | Novo Nordisk Farmaceutica Limitada | $1.326.802 |
| 4661-963-SE14 | 22-07-2014 | Aventis Pharma Holding Gmbh | $824.408 |
| 4661-961-SE14 | 21-07-2014 | Aventis Pharma Holding Gmbh | $1.947.554 |
| 4661-857-SE14 | 08-07-2014 | Novo Nordisk Farmaceutica Limitada | $1.773.100 |
| 4661-834-SE14 | 04-07-2014 | Novofarma Service S.A. | $2.306.863 |
| 4661-817-SE14 | 02-07-2014 | Aventis Pharma Holding Gmbh | $2.921.379 |
| 4586-2456-SE14 | 01-07-2014 | Productos Farmoquimicos Roche Limitada | $5.140.800 |
| 4661-744-SE14 | 12-06-2014 | Aventis Pharma Holding Gmbh | $2.272.162 |
| 4586-2128-SE14 | 12-06-2014 | Productos Farmoquimicos Roche Limitada | $5.140.800 |
| 4661-741-SE14 | 12-06-2014 | Novo Nordisk Farmaceutica Limitada | $392.414 |
| 4661-696-SE14 | 10-06-2014 | Aventis Pharma Holding Gmbh | $3.570.547 |
| 4586-2065-SE14 | 09-06-2014 | Productos Farmoquimicos Roche Limitada | $5.140.800 |
| 4661-625-SE14 | 28-05-2014 | Aventis Pharma Holding Gmbh | $1.947.554 |
| 4661-616-SE14 | 27-05-2014 | Novofarma Service S.A. | $1.922.386 |
| 4661-537-SE14 | 07-05-2014 | Novo Nordisk Farmaceutica Limitada | $2.273.281 |
| 4661-544-SE14 | 07-05-2014 | Aventis Pharma Holding Gmbh | $5.219.316 |
| 4661-487-SE14 | 29-04-2014 | Novofarma Service S.A. | $2.306.863 |
| 4661-449-SE14 | 17-04-2014 | Aventis Pharma Holding Gmbh | $2.447.354 |
| 4586-1357-SE14 | 10-04-2014 | Productos Farmoquimicos Roche Limitada | $1.428.000 |
| 4661-419-SE14 | 09-04-2014 | Aventis Pharma Holding Gmbh | $2.780.602 |
| 4661-417-SE14 | 03-04-2014 | Novofarma Service S.A. | $768.954 |
| 4661-395-SE14 | 31-03-2014 | Novo Nordisk Farmaceutica Limitada | $588.622 |
| 4661-372-SE14 | 27-03-2014 | Aventis Pharma Holding Gmbh | $1.947.554 |
| 4661-353-SE14 | 24-03-2014 | Aventis Pharma Holding Gmbh | $333.200 |
| 4661-336-SE14 | 17-03-2014 | Aventis Pharma Holding Gmbh | $2.596.770 |
| 4586-900-SE14 | 11-03-2014 | Productos Farmoquimicos Roche Limitada | $2.856.000 |
| 4661-308-SE14 | 10-03-2014 | Instituto Sanitas S.A. | $121.380 |
| 4661-313-SE14 | 10-03-2014 | Novofarma Service S.A. | $2.306.863 |
| 4661-269-SE14 | 06-03-2014 | Novo Nordisk Farmaceutica Limitada | $1.633.204 |
| 4661-259-SE14 | 04-03-2014 | Aventis Pharma Holding Gmbh | $3.700.781 |
| 4586-567-SE14 | 19-02-2014 | Productos Farmoquimicos Roche Limitada | $7.140.000 |
| 4661-177-SE14 | 13-02-2014 | Aventis Pharma Holding Gmbh | $2.921.331 |
| 4661-114-SE14 | 31-01-2014 | Novo Nordisk Farmaceutica Limitada | $2.327.521 |
| 4661-105-SE14 | 29-01-2014 | Novofarma Service S.A. | $2.306.863 |
| 4661-96-SE14 | 28-01-2014 | Aventis Pharma Holding Gmbh | $1.947.554 |
| 4586-185-SE14 | 24-01-2014 | Productos Farmoquimicos Roche Limitada | $7.140.000 |
| 4661-37-SE14 | 15-01-2014 | Aventis Pharma Holding Gmbh | $4.722.872 |
| 4661-26-SE14 | 13-01-2014 | Novo Nordisk Farmaceutica Limitada | $2.609.384 |
| 4661-1399-SE13 | 30-12-2013 | Aventis Pharma Holding Gmbh | $1.947.554 |
| 4661-1400-SE13 | 30-12-2013 | Novo Nordisk Farmaceutica Limitada | $714.000 |
| 4586-2340-SE13 | 18-12-2013 | Productos Farmoquimicos Roche Limitada | $5.712.000 |
| 4661-1356-SE13 | 11-12-2013 | Instituto Sanitas S.A. | $364.140 |
| 4661-1331-SE13 | 09-12-2013 | Aventis Pharma Holding Gmbh | $4.722.872 |
| 4586-2254-SE13 | 04-12-2013 | Productos Farmoquimicos Roche Limitada | $8.568.000 |
| 4661-1301-SE13 | 03-12-2013 | Novo Nordisk Farmaceutica Limitada | $294.311 |
| 4661-1176-SE13 | 19-11-2013 | Aventis Pharma Holding Gmbh | $3.895.108 |
| 4586-2115-SE13 | 13-11-2013 | Productos Farmoquimicos Roche Limitada | $5.712.000 |
| 4661-1193-SE13 | 08-11-2013 | Instituto Sanitas S.A. | $303.450 |
| 4661-1177-SE13 | 07-11-2013 | Aventis Pharma Holding Gmbh | $5.044.172 |
| 4661-1109-SE13 | 24-10-2013 | Aventis Pharma Holding Gmbh | $3.570.595 |
| 4661-1115-SE13 | 24-10-2013 | Novo Nordisk Farmaceutica Limitada | $880.505 |
| 4586-1906-SE13 | 10-10-2013 | Productos Farmoquimicos Roche Limitada | $6.426.000 |
| 4661-1051-SE13 | 09-10-2013 | Novo Nordisk Farmaceutica Limitada | $2.413.177 |
| 4661-1050-SE13 | 09-10-2013 | Instituto Sanitas S.A. | $121.380 |
| 4661-963-SE13 | 25-09-2013 | Aventis Pharma Holding Gmbh | $5.992.650 |
| 4586-1697-SE13 | 09-09-2013 | Productos Farmoquimicos Roche Limitada | $5.712.000 |
| 4661-920-SE13 | 09-09-2013 | Novo Nordisk Farmaceutica Limitada | $2.252.384 |
| 4661-895-SE13 | 05-09-2013 | Aventis Pharma Holding Gmbh | $1.298.433 |
| 4661-897-SE13 | 05-09-2013 | Instituto Sanitas S.A. | $262.990 |
| 4661-837-SE13 | 28-08-2013 | Aventis Pharma Holding Gmbh | $4.868.885 |
| 4661-821-SE13 | 26-08-2013 | Novo Nordisk Farmaceutica Limitada | $1.716.789 |
| 4661-789-SE13 | 16-08-2013 | Aventis Pharma Holding Gmbh | $973.825 |
| 4586-1446-SE13 | 12-08-2013 | Productos Farmoquimicos Roche Limitada | $5.712.000 |
| 4661-742-SE13 | 02-08-2013 | Instituto Sanitas S.A. | $262.990 |
| 4661-722-SE13 | 29-07-2013 | Aventis Pharma Holding Gmbh | $5.939.064 |
| 4586-1273-SE13 | 10-07-2013 | Productos Farmoquimicos Roche Limitada | $5.775.665 |
| 4661-643-SE13 | 03-07-2013 | Aventis Pharma Holding Gmbh | $3.570.595 |
| 4661-670-SE13 | 03-07-2013 | Novo Nordisk Farmaceutica Limitada | $1.599.003 |
| 4586-1077-SE13 | 10-06-2013 | Productos Farmoquimicos Roche Limitada | $5.798.216 |
| 4661-575-SE13 | 06-06-2013 | Aventis Pharma Holding Gmbh | $5.092.605 |
| 4661-537-SE13 | 30-05-2013 | Novo Nordisk Farmaceutica Limitada | $1.947.197 |
| 4586-883-SE13 | 15-05-2013 | Productos Farmoquimicos Roche Limitada | $5.815.947 |
| 4661-493-SE13 | 14-05-2013 | Aventis Pharma Holding Gmbh | $2.456.874 |
| 4661-451-SE13 | 06-05-2013 | Novo Nordisk Farmaceutica Limitada | $2.413.177 |
| 4586-747-SE13 | 30-04-2013 | Productos Farmoquimicos Roche Limitada | $1.102.833 |
| 4586-644-SE13 | 16-04-2013 | Productos Farmoquimicos Roche Limitada | $4.284.000 |
| 4661-373-SE13 | 15-04-2013 | Novo Nordisk Farmaceutica Limitada | $2.147.022 |
| 4661-358-SE13 | 11-04-2013 | Aventis Pharma Holding Gmbh | $10.619.340 |
| 4661-295-SE13 | 20-03-2013 | Aventis Pharma Holding Gmbh | $1.947.554 |
| 4586-462-SE13 | 13-03-2013 | Productos Farmoquimicos Roche Limitada | $4.712.400 |
| 4661-238-SE13 | 06-03-2013 | Novo Nordisk Farmaceutica Limitada | $2.147.022 |
| 4661-188-SE13 | 25-02-2013 | Aventis Pharma Holding Gmbh | $9.738.246 |
| 4661-191-SE13 | 25-02-2013 | Aventis Pharma Holding Gmbh | $2.227.451 |
| 4586-277-SE13 | 14-02-2013 | Productos Farmoquimicos Roche Limitada | $1.428.000 |
| 4661-153-SE13 | 11-02-2013 | Aventis Pharma Holding Gmbh | $3.246.082 |
| 4586-182-SE13 | 04-02-2013 | Productos Farmoquimicos Roche Limitada | $2.142.000 |
| 4661-83-SE13 | 01-02-2013 | Novo Nordisk Farmaceutica Limitada | $1.402.796 |
| 4661-86-SE13 | 31-01-2013 | Novofarma Service S.A. | $768.954 |
| 4661-85-SE13 | 31-01-2013 | Aventis Pharma Holding Gmbh | $1.303.252 |
Fuente original:ficha mercadopublico.cl
